- Home
- THQ vs TLRY Comparison
THQ vs TLRY Comparison
Compare THQ & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THQ | TLRY |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.8M | 688.9M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | THQ | TLRY |
|---|---|---|
| Price | $18.68 | $5.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 108.5K | ★ 3.5M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | ★ 7.53% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.14 | $0.36 |
| 52 Week High | $20.39 | $15.70 |
Technical Indicators
Market Signals| Indicator | THQ | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 58.42 | 42.97 |
| Support Level | $18.19 | $5.09 |
| Resistance Level | $18.86 | $7.01 |
| Average True Range (ATR) | 0.28 | 0.21 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 72.59 | 68.95 |
Price Performance
Historical ComparisonAbout THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.